About Us
Company Profile
| Name |
Asahi Meguro Institute, Ltd. |
|---|---|
| Head Office |
541-0044 6-4, Fushimi-machi 2-chome, Chuo-ku, Osaka City (Yoshida Ikkan Building) TEL:06-6223-1451 FAX:06-6223-1453 |
| Kasai Factory |
675-2101 318-1 Aza Kotaninoue-Otsu, Hanjo-cho, Kasai City, Hyogo TEL:0790-49-2361 FAX:0790-49-1329 |
| Founded |
1925 |
| Capital |
35.2 million yen |
| Representative |
President: Kenji Someya |
| Number of Employees |
21 (as of Apr 2026) |
| Main Business |
Manufacture, sale, and export of pharmaceutical ingredients for pharmaceuticals, health foods, animal feed, and other products. |
History
The Meguro Institute, the predecessor of the Asahi Meguro Institute, was established in 1925 by the late Dr. Yōzaburo Meguro as the Osaka Experimental Therapy Institute.
After graduating from the Osaka Prefectural High School of Medicine in 1910, he studied biochemistry and later bacteriology and immunology under Dr. Kiyoshi Shiga at the Institute for Infectious Diseases. At the Kitasato Institute established by Dr. Shibasaburo Kitasato, he devoted 4 years of his life to researching with Professor Shiga. In 1922, he went to Europe and received training guidance from Dr. Holliday at the Pasteur Institute in Belgium and from Dr. Ramon at the Pasteur Institute in Paris. After returning to Japan in May 1925, the Osaka Experimental Therapy Institute was established in Kita Ward, Osaka City.
Chronology of the Meguro Institute
|
1925 |
Osaka Experimental Therapy Institute (Kita Ward, Osaka City) is established |
|---|---|
|
1929 |
Lactobacillus preparation “Zeozenin” is released |
|
1931 |
“Diphtheria hormo vaccine” is released |
|
1937 |
The company is renamed as the “Meguro Institute” “Diphtheria serum” is released |
|
1945 |
Meguro Institute is destroyed due to a fire during the war The company is immediately relocated to an immunization center that belongs to Koda Town, Ikeda City, Osaka. |
|
1948 |
New laboratory is built in Masumi Town, Ikeda City, Osaka. Reorganized as “Meguro Institute Co., Ltd.” |
|
1950 |
Epidemic typhus vaccine is released |
|
1952 |
Sale of Lactobacillus preparation “Zeozenin” is resumed |
|
1958 |
Japanese encephalitis vaccine is released |
|
1968 |
Lactic acid bacteria “Concbiogenin” is released Bacillus subtilis “Bionattomin” is released Both are supplied to pharmaceutical manufacturers as raw materials for gastrointestinal drugs |
|
1977 |
Hepatitis B diagnostic kit “Rebirth Cell” is released The company enters the clinical laboratory tests market |
|
1980 |
Construction of new GMP-compliant Kansai Factory for pharmaceuticals in Kansai City, Hyogo Prefecture (current address) is completed Production system for live bacterial preparations and organ-extracted preparations (currently discontinued) is expanded |
|
1997 |
The company becomes a subsidiary of Maruishi Pharmaceutical Co., Ltd. |
|
2003 |
Kasai Factory is expanded |
|
2014 |
Construction of new facility at the Kasai Factory is completed Ikeda Factory is closed and integrated into the Kasai Factory The company relocates head office to Chuo Ward, Osaka City |
|
2022 |
The company becomes a subsidiary of Teijin Limited |
|
2025 |
The company becomes a subsidiary of Asahi Group Foods, Ltd. and is renamed Asahi Meguro Institute, Ltd. |







